ID: ALA5270847

Max Phase: Preclinical

Molecular Formula: C33H47N7O5S

Molecular Weight: 653.85

Associated Items:

Representations

Canonical SMILES:  C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCNCC3)nc3[nH]cnc23)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O

Standard InChI:  InChI=1S/C33H47N7O5S/c1-6-31(4)15-22(32(5)19(2)7-9-33(20(3)27(31)44)10-8-21(41)26(32)33)45-24(43)17-46-29-25-28(36-18-35-25)38-30(39-29)37-23(42)16-40-13-11-34-12-14-40/h6,18-20,22,26-27,34,44H,1,7-17H2,2-5H3,(H2,35,36,37,38,39,42)/t19-,20+,22-,26?,27+,31-,32+,33+/m1/s1

Standard InChI Key:  ZACMSTQFMZFTJG-RKPWQCSBSA-N

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 653.85Molecular Weight (Monoisotopic): 653.3359AlogP: 3.20#Rotatable Bonds: 8
Polar Surface Area: 162.43Molecular Species: BASEHBA: 11HBD: 4
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.17CX Basic pKa: 11.54CX LogP: 2.66CX LogD: 1.48
Aromatic Rings: 2Heavy Atoms: 46QED Weighted: 0.14Np Likeness Score: 0.53

References

1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y..  (2023)  Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives.,  14  (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004]

Source